A Phase 2 Trial Assessing Osimertinib Activity Against Leptomeningeal Carcinomatosis in EGFR-Mutant Lung Cancer

Akazawa, Y; Nanjo, S; Tamiya, M; Hata, A; Yamaguchi, T; Kumagai, T; Mori, M; Katakami, N

JOURNAL OF THORACIC ONCOLOGY, 2019; 14 (10): S918